Phase II study of 4-demethoxydaunorubicin in advanced ovarian carcinoma

Cancer Treat Rep. 1985 May;69(5):559-60.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adenocarcinoma / drug therapy
  • Adult
  • Aged
  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / therapeutic use*
  • Daunorubicin / adverse effects
  • Daunorubicin / analogs & derivatives*
  • Daunorubicin / therapeutic use
  • Drug Evaluation
  • Female
  • Granulosa Cell Tumor / drug therapy
  • Humans
  • Idarubicin
  • Middle Aged
  • Ovarian Neoplasms / drug therapy*

Substances

  • Antineoplastic Agents
  • Idarubicin
  • Daunorubicin